Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
Sales | 7,958,000 | 7,701,000 | 8,193,000 | 7,775,000 | 7,956,000 |
Cost of Goods | 1,464,000 | 1,383,000 | 2,112,000 | 1,529,000 | 1,455,000 |
Gross Profit | 6,494,000 | 6,318,000 | 6,081,000 | 6,246,000 | 6,501,000 |
Operating Expenses | 3,957,000 | 3,420,000 | 4,282,000 | 3,856,000 | 4,206,000 |
Operating Income | 2,537,000 | 2,898,000 | 1,799,000 | 2,390,000 | 2,295,000 |
Other Income | 71,000 | 105,000 | 17,000 | 53,000 | -16,000 |
Pre-tax Income | 2,608,000 | 3,003,000 | 1,816,000 | 2,443,000 | 2,279,000 |
Income Tax | 891,000 | 859,000 | 557,000 | 705,000 | 651,000 |
Net Income Continuous | 1,707,000 | 2,144,000 | 1,250,000 | 1,738,000 | 1,620,000 |
Net Income | $1,707,000 | $2,144,000 | $1,250,000 | $1,738,000 | $1,620,000 |
EPS Basic Total Ops | 0.59 | 0.74 | 0.43 | 0.60 | 0.56 |
EPS Basic Continuous Ops | 0.59 | 0.74 | 0.43 | 0.60 | 0.56 |
EPS Diluted Total Ops | 0.59 | 0.74 | 0.43 | 0.60 | 0.56 |
EPS Diluted Continuous Ops | 0.59 | 0.74 | 0.43 | 0.60 | 0.56 |
EBITDA(a) | $3,001,000 | $3,283,000 | $2,726,000 | $2,920,000 | $2,756,000 |